Package leaflet: information for the user
Fampyra 10mg prolonged-release tablets
fampridine
1. What Fampyra is and what it is used for
2. What you need to know before you take Fampyra
3. How to take Fampyra
4. Possible side effects
5. How to store Fampyra
6. Contents of the pack and other information
1. What Fampyra is and what it is used for
Fampyra is a medicine used to improve walking in adults (18 years and over) with Multiple Sclerosis (MS) related walking disability. In multiple sclerosis, inflammation destroys the protective sheath around the nerves leading to muscle weakness, muscle stiffness and difficulty walking.
Fampyra contains the active substance fampridine which belongs to a group of medicines called potassium channel blockers. They work by stopping potassium leaving the nerve cells which have been damaged by MS. This medicine is thought to work by letting signals pass down the nerve more normally, which allows you to walk better.
2. What you need to know before you take Fampyra
Tell your doctor and do not take Fampyra if any of these apply to you.
Talk to your doctor or pharmacist before taking Fampyra:
Tell your doctor before you take Fampyra if any of these apply to you.
Do not give Fampyra to children or adolescents under the age of 18 years.
Before starting treatment and during treatment your doctor may check that your kidneys are working properly.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Do not take Fampyra if you are taking any other medicine containing fampridine.
Other medicines that affect the kidneys
Your doctor will be especially careful if fampridine is given at the same time as any medicine which may affect how your kidneys eliminate medicines for example carvedilol, propranolol and metformin.
Fampyra should be taken without food, on an empty stomach.
If you are pregnant, or are planning to become pregnant, tell your doctor before you take Fampyra
Fampyra is not recommended during pregnancy.
Your doctor will consider the benefit of you being treated with Fampyra against the risk to your baby.
You should not breast-feed whilst taking this medicine.
Fampyra may have an effect on people’s ability to drive or use machines, it can cause dizziness. Make sure you’re not affected before you start driving or use machinery.
3. How to take Fampyra
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Fampyra is only available by prescription and under the supervision of doctors experienced in MS.
Your doctor will give you an initial prescription for 2 to 4 weeks. After 2 to 4 weeks the treatment will be reassessed.
One tablet in the morning and one tablet in the evening (12 hours apart). Do not take more than two tablets in a day. You must leave 12 hours between each tablet. Do not take the tablets more often than every 12 hours.
Swallow each tablet whole, with a drink of water. Do not divide, crush, dissolve, suck or chew the tablet. This may increase your risk of side effects.
If your Fampyra is supplied in bottles, the bottle will also contain a desiccant. Leave the desiccant in the bottle, do not swallow it.
Contact your doctor immediately if you take too many tablets.
Take the Fampyra box with you if you go to see the doctor.
In overdose you may notice sweating, minor shaking (tremor), dizziness, confusion, memory loss (amnesia) and fits (seizure). You may also notice other effects not listed here.
If you forget to take a tablet, do not take two tablets at once to make up for a missed dose. You must always leave 12 hours between each tablet.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you have a seizure, stop taking Fampyra and tell your doctor immediately.
If you experience one or more of the following allergic (hypersensitivity) symptoms: swollen face, mouth, lips, throat or tongue, reddening or itching of the skin, chest tightness and breathing problems stop taking Fampyra and see your doctor immediately.
Side effects are listed below by frequency:
Very Common side effects
May affect more than 1 in 10 people:
Common side effects
May affect up to 1 in 10 people:
Uncommon side effects
May affect up to 1 in 100 people
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via:
Ireland
United Kingdom
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Fampyra
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date refers to the last day of that month.
Store below 25°C. Store the tablets in the original packaging in order to protect from light and moisture.
If your Fampyra is supplied in bottles, only one bottle should be opened at a time. After first opening use within 7 days.
Do not throw away any medicines via waste water or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
6. Contents of the pack and other information
You can get a larger print version of this leaflet by calling the local representatives (see list below).
Fampyra is an off-white, film coated, oval biconvex 13 x 8 mm prolonged-release tablet with A10 on one side.
Fampyra is supplied in either blister packs or bottles.
Bottles
Fampyra comes in HDPE (high-density polyethylene) bottles. Each bottle contains 14 tablets and a silica gel desiccant. Each pack contains 28 tablets (2 bottles) or 56 tablets (4 bottles).
Blister packs
Fampyra comes in foil blisters of 14 tablets each. Each pack contains 28 tablets (2 blisters) or 56 tablets (4 blisters).
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer:
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: